Growth hormone secretagogues in pathological states: Diagnostic implications

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 86, Issue 423, 1997, Pages 97-101

  Popovic, V ^a   Micic, D ^a   Damjanovic, S ^a   Obradovic, S ^a   Djurovic, M ^a   Petakov, M ^a   Grudic, D ^a   Golubicic, I ^b   Nikitovic, M ^b   Mitrovic, N ^b   Dieguez, C ^c   Casanueva, F F ^c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Growth hormone releasing hormone; Growth hormone releasing peptide 6; Hexarelin; Metabolic derangements; Neuroendocrine pathologies

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; UNCLASSIFIED DRUG; GROWTH HORMONE RELEASING HEXAPEPTIDE; HUMAN GROWTH HORMONE; OLIGOPEPTIDE;

ACROMEGALY; ADULT; ANOREXIA NERVOSA; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CUSHING SYNDROME; ENDOCRINE DISEASE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROENDOCRINOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROLACTINOMA; METABOLISM; REVIEW; SECRETION;

ANOREXIA NERVOSA; ENDOCRINE SYSTEM DISEASES; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; OLIGOPEPTIDES;

EID: 0030859696     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Bertherat J, Bluet-Pajot M, Epelbaum J. Neuroendocrine regulation of growth hormone. Eur J Endocrinol 1995; 132:12-24
2. Dieguez C, Page M, Scanlon M. Growth hormone neuro-regulation and its alterations in disease states. Clin Endocrinol 1988;28:109-43
3. Casanueva FF. Physiology of growth hormone secretion and action. Endocrinol Metab Clin North Am 1992;21:483-517
4. Dieguez C, Casanueva F. Influence of metabolic substrates and obesity on growth hormone secretion. Trends Endocrinol Metab 1995;6:55-9
5. Momany F, Bowers C, Reynolds G, Hong A, Newlander K. Conformational energy studies and in vitro and in vivo activity data on growth hormone releasing peptides. Endocrinolocy 1984;114:1531-6
6. Ilson B, Jorkasky D, Curnow R, Stole R. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy subjects. J Clin Endocrinol Metab 1989; 69:212-14
7. Pong SS, Chuang LY, Dean D, Nargund R, Patchett AS, Smith R. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 1996;10:57-61
8. Howard A, Feighner S, Cully D, Arena J, Liberator P, Rosenblum C, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273:974-7
9. Micic D, Popovic V, Kendereski A, Macut D, Casanueva FF, Dieguez C. Growth hormone secretion after the administration of GHRP-6, or GHRP-6 combined with GHRH does not decline in late adulthood. Clin Endocrinol 1995;42:191-4
10. Micic D, Popovic V, Kendereski A, Peino R, Dieguez C, Casanueva FF. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man. Clin Endocrinol 1996;45:543-51
11. Arvat E, Gianotti L, Vito L, Imbimbo B, Lenaerts V, Deghendi R, et al. Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 1995;61:51-6
12. Micic D, Mallo F, Peino R, Cordido F, Leal-Cerro A, Garcia-Mayor R, et al. Regulation of growth hormone secretion by the growth hormone releasing peptide (GHRP-6). J Pediatr Endocrinol 1993;6:283-9
13. Leal A, Pumar A, Gargia-Garcia E, Dieguez C, Casanueva F. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clin Endocrinol 1994;41:649-54
14. Tjaden B. Polycystic ovary syndrome: relationship to growth hormone, insulin-like growth factor-I and insulin. Curr Opin Obstet Gynecol 1994;6:279-83
15. Micic D, Kendereski A, Popovic V, Sumarac M, Zoric S, Macut D, et al. Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome. Clin Endocrinol 1996;45:385-90
16. Jacobs M, Nathoe H, Blankestijn P, Stijnen T, Weber R. Growth hormone responses to growth hormone-releasing hormone and clonidine in patients with type I diabetes and in normal controls: effect of age, body mass index and sex. Clin Endocrinol 1996;44:547-53
17. Popovic V, Micic D, Djurovic M, Obradovic S, Casanueva FF, Dieguez C. Absence of desensitization by hexarelin to a subsequent growth hormone (GH) releasing hormone-mediated GH secretion in patients with anorexia nervosa. Clin Endocrinol 1997 (in press)
18. Popovic V, Damjanovic S, Micic D, Petakov M, Dieguez C, Casanueva FF. Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6. J Clin Endocrinol Metab 1994;79:456-60
19. Hanew K, Utsumi A, Sugawara A, Shimiyu Y, Abe K. Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly. J Clin Endocrinol Metab 1994;78:509-12
20. Popovic V, Micic D, Damjanovic S, Djurovic M, Simic M, Gligorovic M, et al. Evaluation of pituitary GH reserve with GHRP-6. J Pediatr Endocrinol Metab 1996;9:289-98
21. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva F. Blocked growth hormone-releasing peptide (GHRP-6) induced GH secretion and absence of the synergic action of GHRP-6 plus GHRH in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 1995;80:942-7
22. Toogood A, Beardwell C, Shalet S. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol 1994; 41:511-16
23. Hoffman D, O'Sullvan A, Baxter R, Ho K. Diagnosis of growth hormone deficiency in adults. Lancet 1994;343:1064-8
24. European Pharmacopoeia Commission: Biological Standardization. Somatotropin. PA/PH/BIO (94) 9. Report of the International Meeting, 7 September 1994, Strasbourg
25. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E, Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur J Endocrinol 1996;134:352-6
26. Shalet S. Radiation-induced growth hormone deficiency. Highlights 1995;3:6-10
27. Toogood A, Ryder D, Beardwell C, Shalet S. The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status. Clin Endocrinol 1995;43:97-103